{"Title": ["Health Care Sector Update for 06/12/2020: GLYC,FGEN,VIE,NVCN", "GlycoMimetics Inc (GLYC) Q1 2020 Earnings Call Transcript", "GlycoMimetics Inc (GLYC) Q4 2019 Earnings Call Transcript", "Wall Street Pros: These 3 Stocks Can Double Next Year", "FDA Approves AZN's Calquence, GLYC's Data To Be Delayed, ENLV Withdraws Offering", "Here's Why BioCryst Pharmaceuticals Popped Today", "Notable Monday Option Activity: GLYC, IDCC, JPM", "Mid-Afternoon Market Update: Dow Falls Over 800 Points; Cars.com Shares Slide", "Health Care Sector Update for 06/12/2020: GLYC,FGEN,VIE,NVCN", "Mid-Morning Market Update: Markets Open Lower; Tyson Foods Earnings Top Views", "Health Care Sector Update for 08/05/2019: GLYC, PRVB, ZYME, JNJ, PFE, ABT, MRK, AMGN", "GlycoMimetics (GLYC) Q2 2019 Earnings Call Transcript", "GlycoMimetics (GLYC) Q1 2019 Earnings Call Transcript", "GlycoMimetics Inc (GLYC) Q4 2018 Earnings Conference Call Transcript", "Pre-Market Earnings Report for March 6, 2019 : DLTR, DCI, INXN, TSG, THO, ANF, CHS, GLYC, AMRC, MEET, OPTN, WHF", "3 Top Biotech Stocks to Buy Right Now", "Mid-Day Market Update: Crude Oil Down Over 1%; Allakos Shares Spike Higher", "Neurocrine Inks Deal with Private Biotech to Make CNS Drugs", "GlycoMimetics (GLYC) Q2 2018 Earnings Conference Call Transcript", "GlycoMimetics Stock Has Substantial Upside", "Earnings Reaction History: GLYCOMIMETICS, 100.0% Follow-Through Indicator, 11.4% Sensitive", "Earnings Reaction History: GLYCOMIMETICS, 100.0% Follow-Through Indicator, 13.9% Sensitive", "Why GlycoMimetics Is Tumbling 19.2% Today", "Should You Buy GlycoMimetics (GLYC) Ahead of Earnings?", "Earnings Reaction History: GLYCOMIMETICS, 100.0% Follow-Through Indicator, 9.4% Sensitive", "Here's What Pfizer's Saying About Its Future", "The 1 Word That Explains Why Pfizer's Future Looks Brighter Than Its Past", "Here's Why GlycoMimetics Could Become a Takeover Target", "Health Care Sector Update for 12/15/2017: APHB,SGRY,GLYC,ECYT,TTPH,CASC", "Health Care Sector Update for 12/15/2017: SGRY,ABT,GLYC,ECYT,TTPH,CASC", "Company News For Dec 13, 2017", "Midday Update: Tax Reform Chatter Drives Dow, S&P 500 To Record Highs", "Pre-Market Earnings Report for March 6, 2018 : TGT, DCI, KLXI, CIEN, GMS, GLYC, MYE, BTE, MTLS, AFI, AMRC, JW.A", "Why This Biotech Stock Is Defying A Hematology-Related Pitfall", "Energy Shares Boost Futures, Focus Shifts to FOMC", "Pre-Market Most Active for Dec 12, 2017 : PTI, COWN, XNET, OAS, KEP, NOK, TEVA, NVO, TS, GLYC, OSTK, TVIX", "Stocks Mixed As Nasdaq Struggles, But These 2 Sectors Outperform", "The Zacks Analyst Blog Highlights: Sangamo Therapeutics, Sarepta Therapeutics, Akebia Therapeutics, Calithera Biosciences and GlycoMimetics", "5 Top-Ranked Drug Stocks that are Broker Favorites", "GlycoMimetics (GLYC) Jumps: Stock Rises 11.9%", "Here's Why GlycoMimetics Is Soaring 24.3% Higher Today", "Why This Biotech Stock Is Defying A Hematology-Related Pitfall", "Energy Shares Boost Futures, Focus Shifts to FOMC", "Are Options Traders Betting on a Big Move in GlycoMimetics (GLYC) Stock?", "Why GlycoMimetics Is Tumbling 13.4% Today", "Pre-Market Most Active for Jun 5, 2017 : FOR, SMFG, TOT, NOK, AAPL, PBYI, BABA, JCP, TLT, LOXO, QQQ, GLYC", "Jazz Pharmaceuticals' Vyxeos NDA Granted Priority Review", "Here's Why GlycoMimetics Rose as Much as 21% Today", "Why Earnings Season Could Be Great for GlycoMimetics (GLYC)", "Pre-Market Most Active for May 22, 2017 : F, HUN, TOT, RDS/B, NVS, FCAU, RDUS, TVIX, NVDA, USLV, XIV, GLYC", "Pre-Market Most Active for May 19, 2017 : PTXP, DYN, RDS/B, FWONK, QQQ, PBR, SBGL, BAC, XIV, NTEST, HALO, GLYC", "GlycoMimetics (GLYC) Shows Strength: Stock Jumps 98.7%", "Health Care Sector Update for 05/19/2017: AZN,GLYC,CLBS", "Health Care Sector Update for 05/19/2017: AVEO,GLYC,CLBS", "Why GlycoMimetics Is Ripping 19% Higher Today", "GlycoMimetics Inc (GLYC) Stock May Find Its Way to Profitability", "Pre-Market Most Active for May 24, 2017 : NOW, FGL, GLYC, FCAU, INO, LOW, STNG, BAC, NVDA, TTD, QQQ, ALNY", "Close Update: Wall Street Regains Composure as Economic Data, Comey Video Soothes Investors", "Health Care Sector Update for 05/18/2017: CUR,GLYC,RPRX", "Here's Why GlycoMimetics (GLYC) Stock Skyrocketed Over 100% Today", "Thursday Sector Leaders: Trucking, Drugs", "Health Care Sector Update for 05/18/2017: ELGX,GLYC,RPRX", "Novartis Buys Selexys on Favorable Phase II Data on SelG1", "Russell 2000 Headed 11% Higher, If Analysts Got The Components Right", "Midday Update: Wall Street Bounces Back as Bullish Data Stifles Early Selling", "7 Stocks with Recent Price Strength for Explosive Returns", "Will TrovaGene (TROV) Pull an Earnings Surprise in Q2?", "Inogen (INGN) Q2 Earnings: Can the Stock Pull a Surprise?", "Pacific Biosciences (PACB) Q2 Earnings: What's in Store?", "Iron Mountain (IRM) to Post Q2 Earnings: What to Expect?", "Can PerkinElmer (PKI) Pull a Surprise this Earnings Season?", "Becton, Dickinson (BDX) Q3 Earnings: What's in the Cards?", "Zacks.com featured highlights: GlycoMimetics, Lion Biotechnologies, AMN Healthcare Services, Gibraltar Industries and Coherent", "Cardinal Health (CAH) Q4 Earnings: Disappointment in Store?", "GlycoMimetics (GLYC) Worth Watching: Stock Surges 13.1%", "Health Care Sector Update for 06/17/2016: INNL,JAGX,GLYC", "Friday Sector Laggards: Drugs, Water Utilities", "Health Care Sector Update for 06/17/2016: BIOS,JAGX,GLYC", "Will GlycoMimetics (GLYC) Continue to Surge Higher?", "The 3 Best Developmental Stage Biotech Stocks Surging Now", "Can Cerner (CERN) Spring a Surprise This Earnings Season?", "Pfizer Starts Phase III Rivipansel Study, GlycoMimetics Up - Analyst Blog", "GlycoMimetics' Leukemia Drug Gets Orphan Status in U.S. - Analyst Blog", "Health Care Sector Update for 04/07/2015: CDTX, GLYC, MRK", "BioMed Realty Inks Lease Agreement with GlycoMimetics in MD - Analyst Blog", "Friday Sector Leaders: Manufacturing, Drugs", "Sector Update: Health Care", "Sector Update: Health Care Stocks Following Broader Markets Highers; GlycoMimetics Jumps More Than 10% After Naming Cancer-Specialist to Board", "GlycoMimetics (GLYC) Shows Strength: Stock Rises 12.1% - Tale of the Tape", "Sector Update: Healthcare", "How GlycoMimetics (GLYC) Stock Stands Out in a Strong Industry - Tale of the Tape", "Should GlycoMimetics (GLYC) Be On Your Radar Now? - Tale of the Tape", "Biotechs dominate IPO calendar, but most post negative returns", "US IPO Recap: Twenty companies file or set terms for IPOs", "4 US IPOs planned for the week of Jan 13", "GlycoMimetics prices upsized IPO at $8 per share", "GlycoMimetics Up on FDA Agreement on Rivipansel Study - Analyst Blog", "Orphan disease biotech GlycoMimetics revives IPO filing, removes original terms", "GlycoMimetics postpones $60 million IPO", "Orphan disease biotech GlycoMimetics sets terms for $60 million IPO", "GlycoMimetics drops IPO price to $8 and increases shares offered"], "Elapsed Time": ["JUN 12, 2020", "MAY 1, 2020", "MAR 4, 2020", "FEB 6, 2020", "NOV 21, 2019", "SEP 23, 2019", "AUG 5, 2019", "AUG 5, 2019", "JUN 12, 2020", "AUG 5, 2019", "AUG 5, 2019", "AUG 2, 2019", "MAY 4, 2019", "MAR 6, 2019", "MAR 5, 2019", "NOV 27, 2018", "AUG 5, 2019", "OCT 10, 2018", "AUG 10, 2018", "AUG 10, 2018", "AUG 9, 2018", "MAY 3, 2018", "MAR 6, 2018", "MAR 5, 2018", "NOV 2, 2018", "FEB 2, 2018", "JAN 9, 2018", "DEC 17, 2017", "DEC 15, 2017", "DEC 15, 2017", "DEC 13, 2017", "DEC 12, 2017", "MAR 5, 2018", "DEC 12, 2017", "DEC 12, 2017", "DEC 12, 2017", "DEC 12, 2017", "DEC 6, 2017", "DEC 5, 2017", "NOV 28, 2017", "DEC 12, 2017", "DEC 12, 2017", "SEP 5, 2017", "JUN 30, 2017", "JUN 5, 2017", "JUN 5, 2017", "JUN 1, 2017", "MAY 25, 2017", "NOV 2, 2017", "MAY 22, 2017", "MAY 19, 2017", "MAY 19, 2017", "MAY 19, 2017", "MAY 19, 2017", "MAY 19, 2017", "MAY 19, 2017", "MAY 24, 2017", "MAY 18, 2017", "MAY 18, 2017", "MAY 18, 2017", "MAY 18, 2017", "MAY 18, 2017", "NOV 22, 2016", "SEP 30, 2016", "MAY 18, 2017", "AUG 4, 2016", "AUG 1, 2016", "AUG 1, 2016", "AUG 1, 2016", "AUG 1, 2016", "JUL 29, 2016", "JUL 29, 2016", "AUG 5, 2016", "JUL 29, 2016", "JUN 24, 2016", "JUN 17, 2016", "JUN 17, 2016", "JUN 17, 2016", "MAY 26, 2016", "MAY 25, 2016", "JUL 29, 2016", "JUN 24, 2015", "MAY 15, 2015", "APR 7, 2015", "AUG 29, 2014", "JUL 18, 2014", "JUL 18, 2014", "JUL 18, 2014", "JUN 24, 2015", "MAY 21, 2014", "APR 11, 2014", "APR 10, 2014", "FEB 6, 2014", "JAN 13, 2014", "JAN 13, 2014", "JAN 10, 2014", "JUL 2, 2014", "DEC 20, 2013", "NOV 8, 2013", "OCT 28, 2013", "JAN 7, 2014"], "Published Date": [], "Link": ["https://www.nasdaq.com/articles/health-care-sector-update-for-06-12-2020%3A-glycfgenvienvcn-2020-06-12", "https://www.nasdaq.com/articles/glycomimetics-inc-glyc-q1-2020-earnings-call-transcript-2020-05-02", "https://www.nasdaq.com/articles/glycomimetics-inc-glyc-q4-2019-earnings-call-transcript-2020-03-04", "https://www.nasdaq.com/articles/wall-street-pros%3A-these-3-stocks-can-double-next-year-2020-02-06", "https://www.nasdaq.com/articles/fda-approves-azns-calquence-glycs-data-to-be-delayed-enlv-withdraws-offering-2019-11-21", "https://www.nasdaq.com/articles/heres-why-biocryst-pharmaceuticals-popped-today-2019-09-23", "https://www.nasdaq.com/articles/notable-monday-option-activity%3A-glyc-idcc-jpm-2019-08-05", "https://www.nasdaq.com/articles/mid-afternoon-market-update%3A-dow-falls-over-800-points-cars.com-shares-slide-2019-08-05", "https://www.nasdaq.com/articles/health-care-sector-update-for-06-12-2020%3A-glycfgenvienvcn-2020-06-12", "https://www.nasdaq.com/articles/mid-morning-market-update%3A-markets-open-lower-tyson-foods-earnings-top-views-2019-08-05", "https://www.nasdaq.com/articles/health-care-sector-update-for-08-05-2019%3A-glyc-prvb-zyme-jnj-pfe-abt-mrk-amgn-2019-08-05", "https://www.nasdaq.com/articles/glycomimetics-glyc-q2-2019-earnings-call-transcript-2019-08-02", "https://www.nasdaq.com/articles/glycomimetics-glyc-q1-2019-earnings-call-transcript-2019-05-04", "https://www.nasdaq.com/articles/glycomimetics-inc-glyc-q4-2018-earnings-conference-call-transcript-2019-03-06", "https://www.nasdaq.com/articles/pre-market-earnings-report-march-6-2019-dltr-dci-inxn-tsg-tho-anf-chs-glyc-amrc-meet-optn", "https://www.nasdaq.com/articles/3-top-biotech-stocks-buy-right-now-2018-11-27", "https://www.nasdaq.com/articles/mid-day-market-update%3A-crude-oil-down-over-1-allakos-shares-spike-higher-2019-08-05", "https://www.nasdaq.com/articles/neurocrine-inks-deal-with-private-biotech-to-make-cns-drugs-2018-10-10", "https://www.nasdaq.com/articles/glycomimetics-glyc-q2-2018-earnings-conference-call-transcript-2018-08-10", "https://www.nasdaq.com/articles/glycomimetics-stock-has-substantial-upside-2018-08-10", "https://www.nasdaq.com/articles/earnings-reaction-history-glycomimetics-1000-follow-through-indicator-114-sensitive-2018", "https://www.nasdaq.com/articles/earnings-reaction-history-glycomimetics-1000-follow-through-indicator-139-sensitive-2018", "https://www.nasdaq.com/articles/why-glycomimetics-tumbling-192-today-2018-03-06", "https://www.nasdaq.com/articles/should-you-buy-glycomimetics-glyc-ahead-of-earnings-2018-03-05", "https://www.nasdaq.com/articles/earnings-reaction-history-glycomimetics-1000-follow-through-indicator-94-sensitive-2018-11", "https://www.nasdaq.com/articles/heres-what-pfizers-saying-about-its-future-2018-02-02", "https://www.nasdaq.com/articles/1-word-explains-why-pfizers-future-looks-brighter-its-past-2018-01-09", "https://www.nasdaq.com/articles/heres-why-glycomimetics-could-become-takeover-target-2017-12-17", "https://www.nasdaq.com/articles/health-care-sector-update-12152017-aphbsgryglycecytttphcasc-2017-12-15", "https://www.nasdaq.com/articles/health-care-sector-update-12152017-sgryabtglycecytttphcasc-2017-12-15", "https://www.nasdaq.com/articles/company-news-for-dec-13-2017-2017-12-13", "https://www.nasdaq.com/articles/midday-update-tax-reform-chatter-drives-dow-sp-500-record-highs-2017-12-12", "https://www.nasdaq.com/articles/pre-market-earnings-report-march-6-2018-tgt-dci-klxi-cien-gms-glyc-mye-bte-mtls-afi-amrc", "https://www.nasdaq.com/articles/why-biotech-stock-defying-hematology-related-pitfall-2017-12-12", "https://www.nasdaq.com/articles/energy-shares-boost-futures-focus-shifts-fomc-2017-12-12", "https://www.nasdaq.com/articles/pre-market-most-active-dec-12-2017-pti-cown-xnet-oas-kep-nok-teva-nvo-ts-glyc-ostk-tvix", "https://www.nasdaq.com/articles/stocks-mixed-nasdaq-struggles-these-2-sectors-outperform-2017-12-12", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-sangamo-therapeutics-sarepta-therapeutics-akebia", "https://www.nasdaq.com/articles/5-top-ranked-drug-stocks-are-broker-favorites-2017-12-05", "https://www.nasdaq.com/articles/glycomimetics-glyc-jumps%3A-stock-rises-11.9-2017-11-28", "https://www.nasdaq.com/articles/heres-why-glycomimetics-soaring-243-higher-today-2017-12-12", "https://www.nasdaq.com/articles/why-biotech-stock-defying-hematology-related-pitfall-2017-12-12", "https://www.nasdaq.com/articles/can-glycomimetics-glyc-run-higher-on-strong-earnings-estimate-revisions-2017-09-05", "https://www.nasdaq.com/articles/are-options-traders-betting-on-a-big-move-in-glycomimetics-glyc-stock-2017-06-30", "https://www.nasdaq.com/articles/why-glycomimetics-tumbling-134-today-2017-06-05", "https://www.nasdaq.com/articles/pre-market-most-active-jun-5-2017-smfg-tot-nok-aapl-pbyi-baba-jcp-tlt-loxo-qqq-glyc-2017", "https://www.nasdaq.com/articles/jazz-pharmaceuticals-vyxeos-nda-granted-priority-review-2017-06-01", "https://www.nasdaq.com/articles/heres-why-glycomimetics-rose-much-21-today-2017-05-25", "https://www.nasdaq.com/articles/why-earnings-season-could-be-great-for-glycomimetics-glyc-2017-11-02", "https://www.nasdaq.com/articles/pre-market-most-active-may-22-2017-f-hun-tot-rdsb-nvs-fcau-rdus-tvix-nvda-uslv-xiv-glyc", "https://www.nasdaq.com/articles/pre-market-most-active-may-19-2017-ptxp-dyn-rdsb-fwonk-qqq-pbr-sbgl-bac-xiv-ntest-halo", "https://www.nasdaq.com/articles/glycomimetics-glyc-shows-strength%3A-stock-jumps-98.7-2017-05-19", "https://www.nasdaq.com/articles/health-care-sector-update-05192017-aznglycclbs-2017-05-19", "https://www.nasdaq.com/articles/health-care-sector-update-05192017-aveoglycclbs-2017-05-19", "https://www.nasdaq.com/articles/why-glycomimetics-ripping-19-higher-today-2017-05-19", "https://www.nasdaq.com/articles/glycomimetics-inc-glyc-stock-may-find-its-way-to-profitability-2017-05-19", "https://www.nasdaq.com/articles/pre-market-most-active-may-24-2017-now-fgl-glyc-fcau-ino-low-stng-bac-nvda-ttd-qqq-alny", "https://www.nasdaq.com/articles/close-update-wall-street-regains-composure-economic-data-comey-video-soothes-investors", "https://www.nasdaq.com/articles/health-care-sector-update-05182017-curglycrprx-2017-05-18", "https://www.nasdaq.com/articles/heres-why-glycomimetics-glyc-stock-skyrocketed-over-100-today-2017-05-18", "https://www.nasdaq.com/articles/thursday-sector-leaders-trucking-drugs-2017-05-18", "https://www.nasdaq.com/articles/health-care-sector-update-05182017-elgxglycrprx-2017-05-18", "https://www.nasdaq.com/articles/novartis-buys-selexys-on-favorable-phase-ii-data-on-selg1-2016-11-22", "https://www.nasdaq.com/articles/russell-2000-headed-11-higher-if-analysts-got-components-right-2016-09-30", "https://www.nasdaq.com/articles/midday-update-wall-street-bounces-back-bullish-data-stifles-early-selling-2017-05-18", "https://www.nasdaq.com/articles/7-stocks-with-recent-price-strength-for-explosive-returns-2016-08-04", "https://www.nasdaq.com/articles/will-trovagene-trov-pull-an-earnings-surprise-in-q2-2016-08-01", "https://www.nasdaq.com/articles/inogen-ingn-q2-earnings%3A-can-the-stock-pull-a-surprise-2016-08-01", "https://www.nasdaq.com/articles/pacific-biosciences-pacb-q2-earnings%3A-whats-in-store-2016-08-01", "https://www.nasdaq.com/articles/iron-mountain-irm-to-post-q2-earnings%3A-what-to-expect-2016-08-01", "https://www.nasdaq.com/articles/can-perkinelmer-pki-pull-a-surprise-this-earnings-season-2016-07-29", "https://www.nasdaq.com/articles/becton-dickinson-bdx-q3-earnings%3A-whats-in-the-cards-2016-07-29", "https://www.nasdaq.com/articles/zacks.com-featured-highlights%3A-glycomimetics-lion-biotechnologies-amn-healthcare-services", "https://www.nasdaq.com/articles/cardinal-health-cah-q4-earnings%3A-disappointment-in-store-2016-07-29", "https://www.nasdaq.com/articles/glycomimetics-glyc-worth-watching%3A-stock-surges-13.1-2016-06-24", "https://www.nasdaq.com/articles/health-care-sector-update-06172016-innljagxglyc-2016-06-17", "https://www.nasdaq.com/articles/friday-sector-laggards-drugs-water-utilities-2016-06-17", "https://www.nasdaq.com/articles/health-care-sector-update-06172016-biosjagxglyc-2016-06-17", "https://www.nasdaq.com/articles/will-glycomimetics-glyc-continue-to-surge-higher-2016-05-26", "https://www.nasdaq.com/articles/3-best-developmental-stage-biotech-stocks-surging-now-2016-05-25", "https://www.nasdaq.com/articles/can-cerner-cern-spring-a-surprise-this-earnings-season-2016-07-29", "https://www.nasdaq.com/articles/pfizer-starts-phase-iii-rivipansel-study-glycomimetics-up-analyst-blog-2015-06-24", "https://www.nasdaq.com/articles/glycomimetics-leukemia-drug-gets-orphan-status-in-u.s.-analyst-blog-2015-05-15", "https://www.nasdaq.com/articles/health-care-sector-update-04072015-cdtx-glyc-mrk-2015-04-07", "https://www.nasdaq.com/articles/biomed-realty-inks-lease-agreement-with-glycomimetics-in-md-analyst-blog-2014-08-29", "https://www.nasdaq.com/articles/friday-sector-leaders-manufacturing-drugs-2014-07-18", "https://www.nasdaq.com/articles/sector-update-health-care-2014-07-18-0", "https://www.nasdaq.com/articles/sector-update-health-care-stocks-following-broader-markets-highers-glycomimetics-jumps", "https://www.nasdaq.com/articles/glycomimetics-glyc-shows-strength%3A-stock-rises-12.1-tale-of-the-tape-2015-06-24", "https://www.nasdaq.com/articles/sector-update-healthcare-2014-05-21-1", "https://www.nasdaq.com/articles/how-glycomimetics-glyc-stock-stands-out-in-a-strong-industry-tale-of-the-tape-2014-04-11", "https://www.nasdaq.com/articles/should-glycomimetics-glyc-be-on-your-radar-now-tale-of-the-tape-2014-04-10", "https://www.nasdaq.com/articles/biotechs-dominate-ipo-calendar-most-post-negative-returns-2014-02-06", "https://www.nasdaq.com/articles/us-ipo-recap-twenty-companies-file-or-set-terms-ipos-2014-01-13", "https://www.nasdaq.com/articles/4-us-ipos-planned-week-jan-13-2014-01-13", "https://www.nasdaq.com/articles/glycomimetics-prices-upsized-ipo-8-share-2014-01-10", "https://www.nasdaq.com/articles/glycomimetics-up-on-fda-agreement-on-rivipansel-study-analyst-blog-2014-07-02", "https://www.nasdaq.com/articles/orphan-disease-biotech-glycomimetics-revives-ipo-filing-removes-original-terms-2013-12-20", "https://www.nasdaq.com/articles/glycomimetics-postpones-60-million-ipo-2013-11-08", "https://www.nasdaq.com/articles/orphan-disease-biotech-glycomimetics-sets-terms-60-million-ipo-2013-10-28", "https://www.nasdaq.com/articles/glycomimetics-drops-ipo-price-8-and-increases-shares-offered-2014-01-07"], "Content": []}